SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-075798
Filing Date
2022-06-29
Accepted
2022-06-29 16:12:05
Documents
16
Period of Report
2022-06-29
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2220042d1_8k.htm   iXBRL 8-K 33761
2 EXHIBIT 99.1 tm2220042d1_ex99-1.htm EX-99.1 23252
6 GRAPHIC tm2220042d1_ex99-1img001.jpg GRAPHIC 7777
7 GRAPHIC tm2220042d1_ex99-1img002.jpg GRAPHIC 2969
8 GRAPHIC tm2220042d1_ex99-1img003.jpg GRAPHIC 2969
  Complete submission text file 0001104659-22-075798.txt   257034

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avdl-20220629.xsd EX-101.SCH 3085
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20220629_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20220629_pre.xml EX-101.PRE 22591
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2220042d1_8k_htm.xml XML 3477
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 221054798
SIC: 2834 Pharmaceutical Preparations